111 (NASDAQ:YI - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.04) earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $527.14 million during the quarter.
111 Stock Down 2.7 %
NASDAQ YI traded down $0.28 on Monday, hitting $10.21. The stock had a trading volume of 32,401 shares, compared to its average volume of 22,029. The company's 50-day moving average is $7.34 and its two-hundred day moving average is $7.35. 111 has a one year low of $4.15 and a one year high of $14.10. The stock has a market cap of $87.32 million, a price-to-earnings ratio of -2.55 and a beta of 0.46.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a "sell (d-)" rating on shares of 111 in a report on Saturday.
Get Our Latest Research Report on 111
111 Company Profile
(
Get Free Report)
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Recommended Stories
Before you consider 111, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 111 wasn't on the list.
While 111 currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
